Though I love oncologic surgery, benign disease can also bring a lot of joy in our daily activity.

Another happy patient. Dodging the bullet of open surgery proposed elsewhere.

#HoLEP .

Most patients with sepsis don't need anti-anaerobic antibiotics. But most get them anyway. Why not, what's the harm?

I worry the harm is considerable.

Our new study in JAMA Internal Medicine: using a 15-month pip-tazo shortage to answer this question.

1/n

jamanetwork.com/journals/jamai…

🔥HotOffThePress🔥

For the first time systematic review assessed patient-outcomes & urodynamics after #LUTS therapies

Therapies providing greater urodynamic benefits also provide greater symptomatic benefits #EBM

Work by Profs Creta, Fusco & the team at authors.elsevier.com/c/1j5Hd14kplyy…

We feel defensive when we experience warranted criticism and feel threatened. Always comes off badly. I’ve developed internal alert. When I feel defensive I try respond something like: “Good point, I could have done better” or “Maybe you’re right, I could have done better by…”

Nice trick!

The EB-StaR study was published at European Urology today! ✅ It is a randomised study comparing en bloc resection of bladder tumour (ERBT) and conventional transurethral resection of bladder tumour (TURBT) in patients with bladder tumour(s) <= 3 cm in size. 🏥 #UroSoMe (1/n)

Thanks to our UK colleagues for leading the way. Finally a trial implementing the new technologies and current paradigms.

🎊🎉

Sorry to read that statistical understanding is at this level in Urology Gold Journal

If only 12 VTE events, reliable analyses IMPOSSIBLE #EBM

Also, too small & not optimal design to study if extended vs limited #thromboprophylaxis required (RCT optimal)
sciencedirect.com/science/articl…

🤯

Para mis pacientes de la normal por favor, no de la salvaje

After 5 months, Finally!

Here's our opinion piece on UGN-102 reverse thermal gel as a chemo ablation agent for intermediate risk bladder cancer.

It will get interesting as TAR-210 delivery system will join this space soon.

Felipe Villacampa

tau.amegroups.org/article/view/1…

INDIGO - vorisidenib is a problematic study that misuses crossover, as Haslam & I defined in 2016, and is not suitable to change practice

Miguel Zugman spent time at UCSF Epidemiology & Biostatistics & did this nice paper
Check it out
authors.elsevier.com/a/1ixfW7tJEDVw…

🔥Just published in Journal of Urology
1️⃣The first US RCT on prophylactic mesh in ileal conduit led by Dr. Hooman Djaladat (2015-2023)
▶️Biologic mesh placement is feasible with no AEs
▶️No protective effect within 2yr FU
🔗auajournals.org/doi/10.1097/JU…
Amer. Urol. Assn. USC Urology Radiology of USC

Postoperative incentive spirometry is a scam

(Hospitals should take all the money they spend on those little spirometers and spend it on early ambulation resources instead!)

Tribute to the European Association of Urology (EAU) leadership including Kari Tikkinen Alberto Briganti for setting aside time/space for session on EBCP and guidelines with international speakers Rod Breau Daniel A. González-Padilla Edouard Philippe Philippe Violette @AlbertoMartini Angie Puerto Nino Nick James